SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to a significant regulatory catalyst as NOAA modernized deep-sea mining permits, allowing for expedited commercial recovery processes, which TMC immediately leveraged by filing an expanded application. The community is buzzing with bullish sentiment, highlighting growing government recognition of critical deep-sea minerals as a national security priority. This policy shift, combined with high short interest, is fueling discussions around a potential squeeze and long-term value.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending following a recent direct offering, which the community largely interprets as a strategic capital raise to fund scaling production for its anticipated role in the AI-driven optical supercycle. Investors are keenly awaiting upcoming announcements from major customers, buoyed by recent technology awards and confirmed partnerships in the high-density, power-efficient optical interconnects market. This is widely viewed as a validation of long-term growth and a key step towards significant commercialization.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to reports of an imminent TikTok US spinoff deal, which includes Oracle, fueling speculation about its expanded role in social media data hosting. This development intensifies the ongoing debate among investors regarding Oracle's long-term growth from its significant AI and cloud infrastructure buildouts. The community is actively discussing whether the TikTok news will serve as a strong catalyst for a rebound or if concerns over the company's substantial debt and market skepticism will lead to a "sell the news" reaction.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals (SXTP) is experiencing extreme volatility following news of a strategic partnership for malaria prevention and a defined significant market opportunity for its babesiosis treatment. This initial surge was swiftly met with a substantial public offering, leading to a sharp decline and fueling intense community debate over potential dilution versus the long-term value of its product pipeline. Traders are closely watching this low-float biotech as bullish enthusiasm clashes with investor caution regarding the offering's impact.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending after the FDA authorized the use of its first commercially manufactured GP2 drug in the ongoing FLAMINGO-01 trial, a move many perceive as significantly de-risking its path to market for breast cancer recurrence prevention. This catalyst has intensified a passionate debate among investors, with longs highlighting strong insider conviction, a tight share float, and high short interest that could lead to a squeeze, while a vocal contingent anticipates a "sell the news" reaction and further downside.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending strongly following a productive FDA meeting that outlined a clear pathway for its Anktiva cancer treatment without requiring new trials, fueling significant optimism for its label expansion. This positive development, coupled with accelerating commercial traction and anticipated global approvals, has intensified a robust bullish sentiment, with the community actively discussing a potential short squeeze amidst mounting pressure on those betting against the company's innovative therapies.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is currently a hot topic amidst evolving discussions surrounding a potential Greenland mineral rights deal and its imminent business update call. Community sentiment is strongly focused on the strategic significance of its Tanbreez heavy rare earth project and a recently announced Saudi joint venture, with many anticipating confirmation of no further dilution and future government involvement despite recent price volatility.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending amidst escalating regulatory scrutiny over social media's impact on youth, as countries like the UK and France consider usage bans similar to Australia's. The community is debating potential catalysts from new partnerships and AI integration against persistent skepticism regarding management's ability to unlock value, with many noting the stock's volatile price action.

iOThree Ltd. is a holding company, which engages in the business of satellite communications and software. It operates through the Satellite Connectivity Solution and Digitalization and Other Solutions segments. The Satellite Connectivity Solution segment offers integrated satellite connectivity solutions through the provision of satellite connectivity services and the sale and lease of satellite network equipment and devices for shipboard network management. The Digitalization and Other Solutions segment is involved in designing digital solutions and providing information technology support and shipboard support services for IT and OT applications enablement. The company was founded by Eng Chye Koh on August 21, 2023 and is headquartered in Singapore.

iOThree Ltd

iOThree Limited Ordinary Shares

iOThree Limited is experiencing a surge in trading activity, driven by recent news of its v.secure/ platform achieving IACS UR E27 type approval from RINA. Community discussions are centered on the stock's exceptionally low float and high short interest, leading to active speculation about a potential squeeze and comparisons to other volatile small-cap runners.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SU Group Holdings Ltd (SUGP) is trending due to intense community discussion centered on its ultra-low share float and significant short interest. Traders are actively speculating about a potential short squeeze, drawing comparisons to other high-volatility "Hong Kong low float" stocks, with sentiment amplified by a high cost to borrow and its presence on the Reg SHO list. While many anticipate a major price breakout, there's also frustration around perceived market manipulation hindering trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Brokerages

Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) has earned an average recommendation of "Buy" from the nine research firms that are presently covering the firm, MarketBeat.com reports. One...

Foghorn Therapeutics (NASDAQ:FHTX) Shares Down 4.1% - Time to Sell?

Foghorn Therapeutics (NASDAQ:FHTX) Shares Down 4.1% - Here's Why...

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire VANCOUVER, BC, Jan...

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) have been given a consensus recommendation of "Buy" by the nine research firms that are currently covering the company...

Wall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to "Buy"

Wall Street Zen raised shares of Foghorn Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

BTIG Research Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to Strong-Buy

BTIG Research raised shares of Foghorn Therapeutics to a "strong-buy" rating in a report on Thursday...

3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment

J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.

Platform Technologies Drive $211B Surge in Precision Cancer Treatment

Platform Technologies Drive $211B Surge in Precision Cancer Treatment Platform Technologies Drive $211B Surge in Precision Cancer Treatment PR Newswire VANCOUVER, BC, Dec. 11, 2025 Issued on behalf...

Foghorn Therapeutics (NASDAQ:FHTX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut Foghorn Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of "Buy" from Analysts

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) have received a consensus recommendation of "Buy" from the eight brokerages that are presently covering the company, MarketBeat...

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Foghorn Therapeutics Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

FHTX
Foghorn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FHTX News

FHTXFoghorn Therapeutics Inc